Ticker: ELYM

Company: Eliem Therapeutics, Inc.

Person: RA CAPITAL MANAGEMENT, LP, director, owns ten percent - or more - of the company

Transaction date: Dec. 11, 2025

Reporting date: Dec. 15, 2025

Average share price: -0.037501648535467974

Bought 20125439.0 shares for 754737.14